Valion Bio (VBIO) EPS (Diluted) (QoQ) (2021 - 2025)
Valion Bio (VBIO) EPS (Diluted) (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Valion Bio | 418,443.64 | -1.78 Mn | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 102.94% |
| Sep 30, 2025 | -28.18% |
| Jun 30, 2025 | 13.10% |
| Mar 31, 2025 | 51.94% |
| Dec 31, 2024 | -2,173.35% |
| Sep 30, 2024 | 30.11% |
| Jun 30, 2024 | 68.32% |
| Mar 31, 2024 | 63.95% |
| Dec 31, 2023 | -90.21% |
| Sep 30, 2023 | -1,974.96% |
| Jun 30, 2023 | 31.85% |
| Mar 31, 2023 | 54.87% |
| Dec 31, 2022 | 12.37% |
| Sep 30, 2022 | 14.65% |
| Jun 30, 2022 | -38.30% |
| Mar 31, 2022 | 64.86% |
| Dec 31, 2021 | -37.64% |
| Sep 30, 2021 | 11.43% |
| Jun 30, 2021 | 7.34% |